Chronic hepatitis B (HBsAg positive > 6 months)
HBeAg negative within six months prior to initiation of peginterferon alfa-2a
HBV DNA < 200 IU/ml during nucleos(t)ide analogue (except Telbivudine) treatment within one month prior to initiation of peginterferon alfa-2a
Compensated liver disease
Age > 18 years
Written informed consent
